AEBSF

From Wikipedia, the free encyclopedia

Template:Cs1 config Template:Refimprove Page Template:Chembox/styles.css has no content.

Template:Chembox IndexlistTemplate:Chembox CompToxTemplate:Chembox Datapage check
AEBSF
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found.
Names
Preferred IUPAC name
4-(2-Aminoethyl)benzene-1-sulfonyl fluoride
Other names
Pefabloc SC
Identifiers
Page Template:Plainlist/styles.css has no content.
3D model (JSmol)
 Page Template:Plainlist/styles.css has no content.
ChEMBL Page Template:Plainlist/styles.css has no content.
ChemSpider Page Template:Plainlist/styles.css has no content.
DrugBank Page Template:Plainlist/styles.css has no content.
EC Number Page Template:Plainlist/styles.css has no content.
MeSH AEBSF
Page Template:Plainlist/styles.css has no content.
RTECS number Page Template:Plainlist/styles.css has no content.
UNII Page Template:Plainlist/styles.css has no content.
  • InChI=1S/C8H10FNO2S/c9-13(11,12)8-3-1-7(2-4-8)5-6-10/h1-4H,5-6,10H2 checkY
    Key: MGSKVZWGBWPBTF-UHFFFAOYSA-N checkY
  • InChI=1/C8H10FNO2S/c9-13(11,12)8-3-1-7(2-4-8)5-6-10/h1-4H,5-6,10H2
    Key: MGSKVZWGBWPBTF-UHFFFAOYAK
  • FS(=O)(=O)c1ccc(cc1)CCN
Properties
C8H10FNO2S.HCl
Molar mass 239.69 g/mol
200 mg/mL[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Template:Chembox Footer/trackingTemplate:Short description

AEBSF or 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride is a water-soluble, irreversible serine protease inhibitor with a molecular weight of 239.5 Da. It inhibits proteases like chymotrypsin, kallikrein, plasmin, thrombin, and trypsin. The specificity is similar to the inhibitor PMSF, nevertheless AEBSF is more stable at low pH values. Typical usage is 0.1 - 1.0 mM. AEBSF (marketed as Pefabloc SC from the company Pentapharm) was first reported for use in biochemistry in 1993, and came into common use for the inhibition serine proteases and of non-protease enzymes such as acetylhydrolases in the mid 1990s.[2]

Mechanism of action

AEBSF is targeted to covalently modify the hydroxyl of serine residues, where it causes an additional 183.0354 Da to be added to each modified residue, but other off-target residues such as tyrosine, lysine, histidine, and the protein N-terminal amino group, have also been reported.[3][4] Due to the substantial frequency of modification of these off-target residues in unoptimized protocols, some users recommend not using AEBSF for highly sensitive proteomics applications, and instead recommend using fresh (and comparatively unstable) PMSF.[3] Both AEBSF and PMSF are sulfonyl fluorides and are sulfonylating agents.[5] Sulfonyl fluorides act by reacting with the hydroxy group of the active site serine residue to form a sulfonyl enzyme derivative. This derivative may be stable for long periods of time except at high pH.[6]

Use in cholesterol regulation studies

AEBSF is extensively used in studies aiming to describe cholesterol regulatory genes due to its potent ability to inhibit Site-1-protease (S1P). This serine protease, located in the Golgi apparatus, is responsible for activating the sterol regulatory element-binding proteins (SREBP). By selectively inhibiting S1P, AEBSF can be used to characterize the downstream result of SREBP inhibition and its influence on cholesterol regulation.

See also

  • PMSF
  • DFP (diisopropyl fluorophosphate), an analogous fluorophosphonate phosphorylating reagent

References

Page Template:Reflist/styles.css has no content.

  1. ^ Page Module:Citation/CS1/styles.css has no content."Pefabloc® SC" (PDF). Pentapharm. Retrieved 22 June 2023.
  2. ^ Page Module:Citation/CS1/styles.css has no content.Dentan C, Tselepis AD, Chapman M, Ninio E (1996). "Pefabloc, 4-[2-aminoethyl]benzenesulfonyl fluoride, is a new, potent nontoxic and irreversible inhibitor of PAF-degrading acetylhydrolase". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1299 (3). Elsevier BV: 353–357. doi:10.1016/0005-2760(95)00226-x. ISSN 0005-2760. PMID 8597590.
  3. ^ a b Page Module:Citation/CS1/styles.css has no content."Web-Based Discussion Forum - Protease Inhibitor Cocktail". The Association of Biomolecular Resource Facilities (ABRF). Retrieved 22 June 2023.{{cite web}}: CS1 maint: deprecated archival service (link)
  4. ^ Page Module:Citation/CS1/styles.css has no content."Accession #: 276 Aminoethylbenzenesulfonylation". Unimod. 2006-10-16. Retrieved 2023-06-21.
  5. ^ Page Module:Citation/CS1/styles.css has no content.Powers JC, Asgian JL, Ekici OD, James KE (2002). "Irreversible inhibitors of serine, cysteine, and threonine proteases". Chem. Rev. 102 (12): 4735–4736. doi:10.1021/cr010182v. PMID 12475205.
  6. ^ Page Module:Citation/CS1/styles.css has no content.Gold AM, Fahrney D (1964). "Sulfonyl Fluorides as Inhibitors of Esterases. II. Formation and Reactions of Phenylmethanesulfonyl α-Chymotrypsin". Biochemistry. 3 (6): 783–791. doi:10.1021/bi00894a009. PMID 14211616.
  • The MEROPS online database for peptidases and their inhibitors: AEBSF[permanent dead link]
  • A Link to the ABRF group usegroup archive with an informative discussion of covalent modifications to proteins resulting from use of AEBSF: [1]
Retrieved from "https://cosmopedia.co/index.php?title=AEBSF&oldid=2230731"